Hologic Announces Third Quarter Fiscal 2008 Operati...( Interest and other expense .....),Health

Interest and

other expense,

net (64,487) - (64,487) (2,126) - (2,126)

(Loss) income

before

provision

for income

taxes (169,809) 509,201 339,392 100,758 11,879 112,637

Provision

for income

taxes 71,435 49,389(3) 120,824 38,290 4,512(4) 42,802

Net (loss)

income $(241,244) $459,812 $218,568 $62,468 $7,367 $69,835

Net (loss)

income per

common and

common

equivalent

share:

Basic $(0.99) $1.90 $0.90 $0.59 $0.07 $0.66

Diluted $(0.99) $1.90 $0.88 $0.57 $0.07 $0.64

(1) - (7) see explanatory notes on following pages.

Explanatory Notes:

(1) To exclude the on-going, non-cash amortization of the intangible assets acquired since fiscal 2006.

(2) To exclude restructuring charges consisting of cash and stock-based compensation related to the resignation of the Company's Executive Chairman in May 2008.

(3) To reflect an estimated effective tax rate of 35.6% on a non-GAAP basis.

(4) To reflect an estimated effective tax rate of 38% on a non-GAAP basis.

(5) To exclude the increase in cost of revenues resulting from the write-up of acquired Cytyc inventory sold during fiscal 2008.

(6) To exclude the non-cash expense associated with the write-off of certain intangible assets acquired from Cytyc in the first fiscal quarter of 2008.

(7) To exclude the non-cash expense associated with the write-off of the acquired in-process research and development related to the acquisition of Cytyc in the first fiscal quarter of 2008.

Use of Non-GAAP Financial Measures:

The Company believes these non-GAAP measures are useful to investors in comparing the results of operations in fiscal 2008 to the comparable period in fis
'/>"/>